Sector valuations Henan Lingrui Pharmaceutical Co., Ltd.
Equities
600285
CNE000001501
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.88 CNY | -2.72% | -2.05% | +33.72% |
08-12 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
05-13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
18.66x | 4.341 | 0.84x | 3.06x | 14.05x | 14.86x | +4.01% | 1.82B | ||
22.8x | 3.024 | 0.92x | 4.93x | 16.36x | 16.87x | +4.27% | 4.62B | ||
19.07x | 2.019 | -10.98x | 2.39x | 10.41x | 14.87x | +1.03% | 3.58B | ||
17.84x | 1.620 | 1.57x | 2.19x | 9.85x | 13.54x | +2.58% | 3.01B | ||
18.73x | 3.209 | 1.12x | - | - | - | -.--% | 2.68B | ||
17.83x | 1.053 | - | - | - | - | - | 1.36B | ||
17.22x | 5.605 | 0.76x | 4.79x | 12.2x | 12.85x | +5.00% | 1.31B | ||
-25.78x | - | 0.46x | 0.43x | -1.27x | -0.82x | -.--% | 815M | ||
9.07x | 0.7765 | 1.19x | 0.7x | 3.64x | 4.16x | +3.78% | 812M | ||
13.59x | 1.289 | 0.92x | 1.03x | 6.67x | 10.19x | +3.12% | 620M | ||
13.92x | 1.633 | 1.39x | 2.88x | 7.56x | 9.05x | +2.24% | 557M | ||
Average | 13.00x | 2.46 | -0.18x | 2.49x | 8.83x | 10.62x | +2.60% | 1.93B | |
Weighted average by Cap. | 17.03x | 2.64 | -1.11x | 3.09x | 11.34x | 13.41x | +2.59% |
MarketScreener is also available in this country: United States.
Switch edition